SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-020233
Filing Date
2020-04-30
Accepted
2020-04-30 17:01:41
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20200331.htm 10-Q 1765001
2 EX-31.1 vktx-ex311_8.htm EX-31.1 20482
3 EX-31.2 vktx-ex312_6.htm EX-31.2 20572
4 EX-32.1 vktx-ex321_7.htm EX-32.1 12857
  Complete submission text file 0001564590-20-020233.txt   6483165

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vktx-20200331.xml EX-101.INS 1370872
6 XBRL TAXONOMY EXTENSION SCHEMA vktx-20200331.xsd EX-101.SCH 52070
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20200331_cal.xml EX-101.CAL 43075
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20200331_def.xml EX-101.DEF 170816
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20200331_lab.xml EX-101.LAB 402719
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20200331_pre.xml EX-101.PRE 309582
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 20836559
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences